Samala Ravi K, Drukker Karen, Shukla-Dave Amita, Chan Heang-Ping, Sahiner Berkman, Petrick Nicholas, Greenspan Hayit, Mahmood Usman, Summers Ronald M, Tourassi Georgia, Deserno Thomas M, Regge Daniele, Näppi Janne J, Yoshida Hiroyuki, Huo Zhimin, Chen Quan, Vergara Daniel, Cha Kenny H, Mazurchuk Richard, Grizzard Kevin T, Huisman Henkjan, Morra Lia, Suzuki Kenji, Armato Samuel G, Hadjiiski Lubomir
Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD, 20993, United States.
Department of Radiology, University of Chicago, Chicago, IL, 60637, United States.
BJR Artif Intell. 2024 Apr 29;1(1):ubae006. doi: 10.1093/bjrai/ubae006. eCollection 2024 Jan.
Innovation in medical imaging artificial intelligence (AI)/machine learning (ML) demands extensive data collection, algorithmic advancements, and rigorous performance assessments encompassing aspects such as generalizability, uncertainty, bias, fairness, trustworthiness, and interpretability. Achieving widespread integration of AI/ML algorithms into diverse clinical tasks will demand a steadfast commitment to overcoming issues in model design, development, and performance assessment. The complexities of AI/ML clinical translation present substantial challenges, requiring engagement with relevant stakeholders, assessment of cost-effectiveness for user and patient benefit, timely dissemination of information relevant to robust functioning throughout the AI/ML lifecycle, consideration of regulatory compliance, and feedback loops for real-world performance evidence. This commentary addresses several hurdles for the development and adoption of AI/ML technologies in medical imaging. Comprehensive attention to these underlying and often subtle factors is critical not only for tackling the challenges but also for exploring novel opportunities for the advancement of AI in radiology.
医学影像人工智能(AI)/机器学习(ML)的创新需要广泛的数据收集、算法进步以及涵盖可推广性、不确定性、偏差、公平性、可信度和可解释性等方面的严格性能评估。要使AI/ML算法广泛集成到各种临床任务中,需要坚定致力于克服模型设计、开发和性能评估中的问题。AI/ML临床转化的复杂性带来了重大挑战,需要与相关利益相关者合作,评估对用户和患者有益的成本效益,在AI/ML生命周期中及时传播与稳健运行相关的信息,考虑监管合规性,以及建立真实世界性能证据的反馈循环。本评论探讨了医学影像中AI/ML技术开发和应用的几个障碍。全面关注这些潜在且往往微妙的因素不仅对于应对挑战至关重要,而且对于探索放射学中AI进步的新机会也至关重要。